Envoy Medical Inc (COCH) 13F Holders & Ownership Data (33 Funds, Q2 2026)

COCH ranks #7245 out of 37503 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

33 institutions disclose a position in COCH, but none treat it as a major bet — even Bleichroeder LP, its most concentrated holder, allocates just 0.9% of its own portfolio to it.

Geode Capital Management, LLC has added to its COCH position for two straight quarters, increasing it by $364.0K to reach $429.1K today.

COCH reported a net loss of $23.4M over the trailing twelve months.

• Not yet profitable — net loss of $23.4M over the trailing twelve months
• Revenue declined 6.8% year over year
• Net income declined year over year, from -$21.3M to -$23.4M
• Operating cash flow was negative, using $18.2M in cash
• Current ratio of 0.54x — below the conventional 1.5x liquidity buffer